pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,408 catalysts · 7,021 phase readout · 2,430 8k filing · 386 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: phase readout×type: adcom×clear all
type
  • phase readout7,021
  • 8k filing2,430
  • earnings386
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ENROLLING_BY_INVITATIONphase readoutNCT07762144: Clinical Cohort Construction Program of Peking University Third Hospital

Sponsor: Peking University Third Hospital. Phase: . Conditions: Post-Cardiac Arrest Syndrome

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06542744: Comparison of the Flexibility of the Perineum in Primiparous Women Using the Medical Device Emagina During 90 Days of Their Pregnancy Compared to Those Having a Standard Pregnancy Follow-up

Sponsor: Mumming. Phase: NA. Conditions: Pregnancy, Childbirth

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07234864: Study to Assess Safety, Tolerability, PK, and PD of Multiple Doses of ZE63-0302 Administrated Orally in T2DM Patients.

Sponsor: Eilean Therapeutics. Phase: PHASE1. Conditions: Type 2 Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07061964: Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT05739864: Superdonor FMT in Patients With Ulcerative Colitis

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: PHASE1. Conditions: Active Ulcerative Colitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05300464: A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

Sponsor: Umbria Bioengineering Technologies. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06125509: SHARE Project Define

Sponsor: Florida State University. Phase: . Conditions: HIV

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07749599: Comparison Between Traditional Bipolar Radiofrequency and Cooled Radiofrequency in Sacroiliac Joint Pain Patients

Sponsor: Assiut University. Phase: NA. Conditions: Sacroiliac Joint Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07440199: Comparison of SPSIP Block and SAP Block in Non-Intubated Uniportal VATS.

Sponsor: Firat University. Phase: NA. Conditions: This Study Evaluates the Effects of Different Fascial Plane Blocks on Intraoperative Anesthesia and Analgesic Consumption in Non-intubated VATS Procedures

full page →ctgov ↗
›RECRUITINGphase readoutNCT06599099: Deep Brain Stimulation of Treatment-Resistant Bipolar Depression

Sponsor: Wayne Goodman MD. Phase: NA. Conditions: Bipolar Depression

full page →ctgov ↗
›SUSPENDEDphase readoutNCT06391099: Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Sponsor: Ohio State University Comprehensive Cancer Center. Phase: NA. Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07393087: Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries

Sponsor: Centre Hospitalier Universitaire Vaudois. Phase: NA. Conditions: Cardiac Surgery Recovery, Inflammation, Complex Cardiovascular Surgery With Cardiopulmonary Bypass, Cytokine Storm, Pediatric Open Heart Surgery

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07146893: Feasibility Study for Repurposing RET Inhibitors

Sponsor: University of Oklahoma. Phase: EARLY_PHASE1. Conditions: Cachexia-Anorexia Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07133893: Transcranial Photobiomodulation in Anxiety Disorders

Sponsor: Francisco Gonzalez-Lima, PhD. Phase: NA. Conditions: Symptoms of Anxiety

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07375693: Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients

Sponsor: Bangladesh Medical University. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT05978193: Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Sponsor: Shanghai Chest Hospital. Phase: PHASE2. Conditions: Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07022093: Effects of Custom-Designed 3D-Printed and CAD-CAM Insoles on Individuals With Flexible Flatfoot

Sponsor: GÖZDE KESİKBAŞ. Phase: NA. Conditions: Pes Planus

full page →ctgov ↗
›COMPLETEDphase readoutNCT06375421: Pilot and Feasibility of MEMI for Chronic Traumatic Brain Injury

Sponsor: Vanderbilt University Medical Center. Phase: NA. Conditions: Traumatic Brain Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07282821: Bempedoic Acid Therapy for Polycystic Kidney Disease

Sponsor: Kenneth Hallows. Phase: PHASE2. Conditions: ADPKD (Autosomal Dominant Polycystic Kidney Disease)

full page →ctgov ↗
›RECRUITINGphase readoutNCT04061421: Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

Sponsor: Michael Savona. Phase: PHASE1. Conditions: MDS/MPN

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07709221: Effects of Hirudotherapy, Phytotherapy, and Forest Therapy in Adults With Reduced Work Capacity or Special Needs

Sponsor: Klaipėda University. Phase: NA. Conditions: Participation Level Below 55% and/or Special Needs

full page →ctgov ↗
›RECRUITINGphase readoutNCT05330221: Project 2: ACHIEVE- HF

Sponsor: Henry Ford Health System. Phase: NA. Conditions: Heart Failure, Hypertension

full page →ctgov ↗
›COMPLETEDphase readoutNCT07043621: When to Block? Timing of Scalp Block in Craniotomy

Sponsor: Sakarya University. Phase: NA. Conditions: Scalp Block, Regional Anesthesia, Craniotomy Surgery, QoR-40

full page →ctgov ↗
›COMPLETEDphase readoutNCT05521321: Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit

Sponsor: Stanford University. Phase: NA. Conditions: Cannabis Use

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05060016: A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)

Sponsor: Amgen. Phase: PHASE2. Conditions: Relapsed/Refractory Small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07179406: The Effect of Spinal Cord Stimulators on Restless Leg Syndrome

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Restless Leg Syndrome (RLS), Spinal Cord Stimulation (SCS)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07158606: Understanding Treatment Outcomes and Immunologic Mechanisms in Altuviiio Immune Tolerance Induction

Sponsor: Versiti Blood Health. Phase: PHASE4. Conditions: Hemophilia A With Inhibitor

full page →ctgov ↗
›COMPLETEDphase readoutNCT07419906: Effect of Introducing Digital Multimedia Nursing on Improving With COPD

Sponsor: Fu Jen Catholic University Hospital. Phase: NA. Conditions: COPD,Pulmonary Disease, Chronic Obstructive ,Pulmonary Disease, Chronic Obstructive

full page →ctgov ↗
›RECRUITINGphase readoutNCT06709404: Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers

Sponsor: Wake Forest University Health Sciences. Phase: NA. Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT03898804: An Early Feasibility Study of the ReHAB System

Sponsor: University Hospitals Cleveland Medical Center. Phase: NA. Conditions: Tetraplegia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07579884: To Evaluate the Safety and Efficacy of RP902 Tablets

Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd.. Phase: PHASE2. Conditions: Mild Cognitive Impairment (MCI)

full page →ctgov ↗
›COMPLETEDphase readoutNCT05233384: Genomics of Fibrin Clot Structure in Patients With Constitutional Dysfibrinogenemia

Sponsor: University Hospital, Clermont-Ferrand. Phase: . Conditions: Hereditary Dysfibrinogenemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07273084: Multidisciplinary Intervention for Non-Cancer Chronic Pain: Pilot Study

Sponsor: Victor Ortiz Mallasen. Phase: NA. Conditions: Non-cancer Pain, Chronic Non-cancer Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT04346784: Cognitive Control Emotion Training to Prevent Major Depression in Youth At-Risk

Sponsor: Hunan Normal University. Phase: NA. Conditions: Depressive Symptoms, Remited Major Depressive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT06907784: PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)

Sponsor: NHS Greater Glasgow and Clyde. Phase: NA. Conditions: Pharmacogenomic Drug Interaction

full page →ctgov ↗
›COMPLETEDphase readoutNCT05090384: Pediatric GVHD Low Risk Steroid Taper Trial

Sponsor: John Levine. Phase: PHASE2. Conditions: Acute Graft vs Host Disease, Allogeneic Bone Marrow Transplantation, Adverse Effects

full page →ctgov ↗
›COMPLETEDphase readoutNCT05089084: Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)

Sponsor: Arrowhead Pharmaceuticals. Phase: PHASE3. Conditions: Familial Chylomicronemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07775833: Study Protocol: The Efficacy of Mushroom to Reduce Cognitive Decline in At-Risk Middle-aged Adults and Young-olds Living in the Community

Sponsor: National University of Singapore. Phase: NA. Conditions: Dementia, Cognitive Assessment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06334133: Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Sponsor: vTv Therapeutics. Phase: PHASE3. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›TERMINATEDphase readoutNCT02802033: A Multicenter Prospective Registry for the Management of Degenerative Spine Disorders

Sponsor: AO Innovation Translation Center. Phase: . Conditions: Degenerative Diseases, Spinal Cord

full page →ctgov ↗
›COMPLETEDphase readoutNCT07656233: Effect of Isoflavone and Vitamin D Supplementation on Serum Vitamin D Levels, Body Composition, Inflammatory Markers, and Quality of Life in Patients With Inflammatory Bowel Disease

Sponsor: Indonesia University. Phase: NA. Conditions: Ulcerative Colitis (UC), Crohn Disease (CD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06964633: The Ku Ola Project: Enhancing Health Promotion Among Native Hawaiian Men.

Sponsor: University of Hawaii. Phase: NA. Conditions: Health Promotion, Health

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05582447: Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: . Conditions: Cholestasis, Red Cell Membrane and Enzyme Abnormalities

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06582147: The Social Determinants of Health Screening and Referral Project

Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Preterm Birth

full page →ctgov ↗
›RECRUITINGphase readoutNCT05827549: Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia

Sponsor: Ho Joon Im. Phase: PHASE2. Conditions: Acute Lymphoid Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT04419649: A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

Sponsor: Takeda. Phase: PHASE2. Conditions: Myelodysplastic Syndromes, Cytopenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03932136: Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: PHASE3. Conditions: Clinical High Risk Syndrome of Psychosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07299136: Evaluating the Effect of Hugging and Praying on Traumatic Birth Perception, Birth Pain, and Birth Anxiety

Sponsor: NURTEN ÖZÇALKAP. Phase: NA. Conditions: The Effect of Hugging and Praying on Traumatic Birth Perception, Pain, and Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT05672836: ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement

Sponsor: Duk-Woo Park, MD. Phase: PHASE4. Conditions: Aortic Valve Stenosis, Heart Failure

full page →ctgov ↗
›RECRUITINGphase readoutNCT07140211: Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis

Sponsor: Marc Blondon. Phase: PHASE3. Conditions: Venous Thromboembolism (VTE), Postpartum

full page →ctgov ↗
← prev
page 144 of 149
next →